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Abstract
Background: Over a hundred years ago, Wolff originally observed that bone growth and
remodeling are exquisitely sensitive to mechanical forces acting on the skeleton. Clinical studies
have noted that the size and the strength of bone increase with weight bearing and muscular activity
and decrease with bed rest and disuse. Although the processes of mechanotransduction and
functional response of bone to mechanical strain have been extensively studied, the molecular
signaling mechanisms that mediate the response of bone cells to mechanical stimulation remain
unclear.
Results: Here, we identify a novel germline mutation at the mouse Bone morphogenetic protein 5
(Bmp5) locus. Genetic analysis shows that the mutation occurs at a site encoding the proteolytic
processing sequence of the BMP5 protein and blocks proper processing of BMP5. Anatomic studies
reveal that this mutation affects the formation of multiple skeletal features including several muscle-
induced skeletal sites in vivo. Biomechanical studies of osteoblasts from these anatomic sites show
that the mutation inhibits the proper response of bone cells to mechanical stimulation.
Conclusion: The results from these genetic, biochemical, and biomechanical studies suggest that
BMPs are required not only for skeletal patterning during embryonic development, but also for
bone response and remodeling to mechanical stimulation at specific anatomic sites in the skeleton.
Background
An area of significant interest in orthopaedics and rehabil-
itation medicine is the effect of mechanical loading on
bone formation and remodeling. Mechanical stimulation
plays an important role in determining bone mass and
density in the adult skeleton, as well as susceptibility to
conditions such as fractures or osteoporosis. It has long
been observed that bone mass and mineral density can be
altered at very specific sites of the skeleton in response to
mechanical stimulation during exercise, as seen in
increased size and cortical thickness of the arm bone from
the dominant side in tennis players [1-3] and the
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weight lifters [4] or in the heel bone of runners [5]. In gen-
eral, increased exercise or muscular loading will increase
bone mass [6,7] or bone density [8,9]. In contrast,
decreased loading will reduce osteogenic activity, as seen
in the bones of test animals in space flight [10] or of
patients in prolonged bed rest [11].
Since Wolff's observation in 1892 that mechanical stress is
a primary determinant in bone adaptation [12], extensive
studies have been performed to understand how bone
responds to its mechanical environment. Frost proposed a
"mechanostat" theory [13] in which the skeleton senses
mechanical stimuli that are above a certain threshold and
bone formation is activated. After cell-mediated bone
remodeling, a feedback system resets this threshold. How-
ever, the exact mechanism by which this mechanostat
converts biophysical force to a cellular response is
unknown. Various mechanisms have been proposed to
involve hydrostatic pressure [14,15], mechanical stretch
[16-19], fluid shear [20-22], and others. The signals acti-
vated by these mechanisms have been postulated to act
via mechanically sensitive ion channels [23-25], the
integrin-cytoskeleton pathway [26-28], phospholipase C
[17,29,30], or G protein cascades [31,32] to trigger a cel-
lular response.
Bone morphogenetic proteins (BMPs) belong to the
Transforming growth factor-beta (TGF-β) family of
secreted signaling molecules [33]. Although previous
studies have revealed much about the important role of
BMPs in skeletal patterning in embryogenesis, many of
these studies were limited by two issues. First, since BMPs
are required for multiple aspects of organogenesis, loss of
function mutations often produce animals with prenatal
lethality due to pleiotropy [34-37]. Second, multiple coex-
pressing BMPs can produce functional redundancy and
mask the effect of loss of function of a single BMP [38-40].
Previous null mutations identified at the short ear/Bmp5
locus have shown that early condensation and growth of
cartilage precursors in the ear, rib, and vertebra require
BMPs [41,42]. In 1987, a new Bmp5 mutation causing
unusually short ears in mice arose spontaneously at The
Jackson Laboratory. To gain further insight into the role of
Bmp5 in skeletal development, these mice were used to
identify the location of this novel Bmp5 mutation and its
effect on the processing and activity of BMP5.
To further investigate the role of BMPs in development,
mice which were homozygous for this novel Bmp5 muta-
tion were generated. Our findings indicate that the muta-
tion disrupts the processing of the BMP5 peptide and may
inactivate BMP5. Furthermore, these mutant mice dis-
played severe defects at specific skeletal structures that
were even more severe than those of Bmp5 null mutants.
Some of the skeletal defects were observed at sites of bone-
muscle interaction. Biomechanical studies show that
mutant osteoblasts from these sites failed to respond
appropriately to mechanical strain and may implicate
BMPs as the endogenous signals for bone formation in
response to mechanical stimulation.
Results
Bmp5 cleavage mutation disrupts the proteolytic 
processing of the BMP5 protein
Sequencing of this newly discovered Bmp5 mutation
revealed a correctly spliced Bmp5 transcript with a G-to-A
substitution at base 932 of the Bmp5 coding region (Fig.
1a, b). This change destroys a Taq1 site in the second exon
(Fig. 1c), providing a simple assay for following the muta-
tion in genetic crosses.
Most TGF-β superfamily proteins are synthesized as larger
precursors that are cleaved at an RXXR consensus site by
proprotein convertase endoproteases to generate an N-ter-
minal pro domain and a C-terminal signaling domain
[43,44]. The G-to-A mutation changes the first arginine in
the RXXR processing site of BMP5 to a glutamine (Fig. 1a).
To test whether the Arg311Gln mutation disrupts BMP5
protein processing, we expressed the wild-type or mutant
forms in COS-7 cells and analyzed conditioned media by
Western blot analysis with antibodies raised to the pro
and mature regions of BMP5. Cells transfected with the
wild-type construct produced BMP5 protein bands of ~40
kDa and ~20 kDa, consistent with the expected sizes of the
cleaved BMP5 pro and mature domains (Fig. 1d). Both
antibodies also detected a minor protein band of ~55 kDa
(Fig. 1d), suggesting that some secreted BMP5 protein was
unprocessed. Cells expressing mutant BMP5 produced
only the unprocessed ~55 kDa protein form (Fig. 1d),
confirming that the mutation in the RXXR site blocks nor-
mal proteolytic cleavage. We termed this mutation Bmp5clv
to denote the lesion at the cleavage site.
Bmp5clv mutants exhibit an array of skeletal defects
Mutations in the RXXR site of other TGF-β family mem-
bers have inhibited the processing and activity of the cor-
responding protein [45-48]. Such mutations also have
acted as dominant-negative mutations that block the
function of other coexpressed TGF-β members, presuma-
bly by sequestering them into inactive heterodimer com-
plexes with the unprocessed mutant subunits [45,47].
Mice heterozygous for the Bmp5clv mutation showed mild
skeletal defects not seen in wild-type or +/Bmp5null mice,
including reduction of the spinous process at the second
thoracic vertebrae (data not shown). Such defects are con-
sistent with a mild dominant-negative effect observed
when the Bmp5clv allele is present in single copy, consist-Page 2 of 13
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Bmp5clv, a Bmp5 cleavage sequence mutation, disrupts the proteolytic processing of the BMP5 proteinFigure 1
Bmp5clv, a Bmp5 cleavage sequence mutation, disrupts the proteolytic processing of the BMP5 protein. (a) Sche-
matic of the Bmp5 open reading frame showing the leader signal (LEAD), pro (PRO) and mature (MAT) domains and the puta-
tive proteolytic processing site (scissors). The G-to-A mutation (*) at nucleotide 932 of the Bmp5clv allele is predicted to 
destroy a Taq1 restriction site and to disrupt the first arginine residue in the putative conserved "RXXR" cleavage sequence in 
BMP5 (box). "1" and "2" denote positions of PCR primers used in typing the Bmp5clv allele. (b) Partial sequence traces showing 
the G-to-A substitution (*) in Bmp5clv mutant mice. This alteration is the only nucleotide difference in the Bmp5 coding region 
between wild-type (wt) and Bmp5clv mice. (c) Confirmation of mutation in genomic DNA. A 158-bp PCR product (gray arrow-
head) containing the site of the Bmp5clv mutation is cleaved by Taq1 into 67- and 91-bp fragments (black arrowheads) in wild-
type mice, partially cleaved in Bmp5clv/+ heterozygous mice, and not cleaved in Bmp5clv/Bmp5clv mice. (d) COS-7 cells were 
transfected with a mammalian expression vector (vec) or the same vector driving expression of wild-type (wt) or mutant 
(Bmp5clv) BMP5 protein. Secreted proteins were analyzed by Western blot with antibodies against the pro (anti-PRO) or 
mature (anti-MAT) domain of murine BMP5. Most of the wild-type protein expressed was in the smaller cleaved form, whereas 
all the detectable mutant protein was non-processed. No appreciable signal was detected by either antibody in the control 
cells. (e) A proposed dominant-negative mechanism for the Bmp5clv mutation. Wild-type BMP5 peptides are cleaved at the pro-
teolytic site to form functional dimers with another wild-type copy of BMP5 (gray bar) or another related BMP (black bar). 
Cleavage mutants produce non-processed BMP5 peptides that bind other non-processed BMP5 peptides to form inactive 
homodimers or bind and sequester wild-type BMP5 or other related BMPs in defective heterodimers.
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tions in other TGF-β members [45,47].
We expect homozygosity for the mutation to further
decrease the activity of BMP5 and increase the production
of the non-processed BMP5 molecules that may inactivate
other coexpressed BMPs. To determine the effect of this
mutation on homozygotes carrying this allele, we crossed
heterozygous carriers of the Bmp5clv mutation and gener-
ated viable Bmp5clv/Bmp5clv homozygotes, but at rates ~10-
times lower than Mendelian predictions (4/156 progeny,
P < 0.001). Despite the increased prenatal lethality, some
Bmp5clv homozygotes survived with normal life spans and
fertility. Among these surviving homozygous Bmp5clv
mice, we noted more severe defects than those seen with
age-controlled Bmp5null homozygotes, including shorter
external ears (wild-type: 6.4 ± 0.4 mm, null: 4.8 ± 0.2 mm,
Bmp5clv: 2.9 ± 0.2 mm; P < 0.01), loss of lesser horns of the
hyoid (Fig. 2a), more misshapen xiphisternum and miss-
ing ribs (Fig. 2f), less calcification of thyroid cartilage (Fig.
2a), abnormal bony fusion (fused posterior sternum; Fig.
2f), and reduced or absent processes on the sixth cervical
(Fig. 2b), second thoracic (Fig. 2d), and lumbar vertebrae
(Fig. 2e). The spectrum of phenotypes, and the consistent
Bmp5clv mutation causes more severe skeletal defects than a Bmp5 null (Bmp5null) mutationFigure 2
Bmp5clv mutation causes more severe skeletal defects than a Bmp5 null (Bmp5null) mutation. Alizarin red-stained 
bones of 12-week +/+, Bmp5null/Bmp5null, and Bmp5clv/Bmp5clv mice show the following: (a) shortening of the greater horn (gh) 
and lesser horn (lh) of the hyoid bone and decreased calcification of the thyroid cartilage (tc), (b) absence of anterior tubercles 
(at) and thinning of the neural arch (na) of the 6th cervical vertebra, (c) reduction of the sesamoid (s) and nearly complete loss 
of the deltoid tuberosity (dt) of the humerus, (d) absence of the spinous process (sp) of the 2nd thoracic vertebra, (e) absence 
of the transverse process (tp) and anapophysis (a) of the 3rd lumbar vertebra, and (f) abnormal fusion of posterior sternal seg-
ments and loss of the xiphoid process (x) at the end of the sternum in Bmp5clv/Bmp5clv mice.Page 4 of 13
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suggest that the Bmp5clvmutation leads to loss rather than
gain of BMP5 activity.
Bmp5clv mutants display a deficiency at a 
mechanosensitive site of the skeleton
An interesting new phenotype in Bmp5clv mice is marked
reduction or complete elimination of the deltoid crest on
the humerus bone (Fig. 2c). The deltoid crest is a promi-
nent bony ridge that is the insertion site for the deltoid
muscle, and it normally forms in response to mechanical
interaction between muscle and bone. In paralyzed ani-
mals or those exhibiting genetically defective muscle for-
mation, the deltoid crest does not form [49,50]. In
contrast, mutant animals showing abnormal increases in
muscle mass develop bigger deltoid tuberosities [51].
The deltoid muscle remained present in Bmp5clv/Bmp5clv
mutants, suggesting that the deltoid crest defect was likely
due to changes in the humerus bone. In situ hybridization
showed Bmp5 expression in the developing deltoid crest
of the humerus (Fig. 3b), and coexpression of the Bmp2
and Bmp6 genes in similar regions (Fig. 3c, d). The coex-
pression of multiple Bmps may explain why the deltoid
crest is only mildly reduced in Bmp5nullmice but com-
pletely eliminated in Bmp5clv mice. The expression of mul-
tiple Bmp genes at the deltoid crest and the defect of this
structure in Bmp5clv mutants suggest that Bmp signaling is
important at this mechanosensitive site.
Bmp5clv mutation alters the response of deltoid crest 
osteoblasts to mechanical stimulation
The loss of a prominent muscle-induced skeletal feature in
Bmp5clv mice suggests that Bmp signaling plays a key role
in bone cells' response to mechanical activity. To test this
Multiple Bmps are expressed at the deltoid tuberosityFigure 3
Multiple Bmps are expressed at the deltoid tuberosity. In situ hybridization analysis of the developing deltoid tuberosity 
at embryonic day 13.5 with antisense probes to (a) collagen 2, (b) Bmp5, (c) Bmp2, or (d) Bmp6 shows expression of multiple 
Bmps at the developing deltoid tuberosity (arrowheads). Control sense probes did not detect any appreciable signal (data not 
shown).Page 5 of 13
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tuberosity of 10-month-old wild-type and Bmp5clv mice
and subjected the cells to 24 hours of cyclic uniform radial
strain in culture. The stretch regimen we applied (10-sec-
ond maximum 15% elongation, then 10-second relaxa-
tion, frequency 0.05 Hz or 3 cycles/minute) is similar to
the mechanical stimulation known to induce cellular
responses in cultured osteoblasts [18,19]. After 24-hour
cyclic strain, control osteoblasts became spindle-shaped,
showed elongation of cellular processes, and were largely
oriented perpendicular to the radial strain field (Fig. 4 and
Table 1). In contrast, osteoblasts from the deltoid tuberos-
ity of the Bmp5clv mice displayed no significant changes in
morphology or orientation after mechanical strain (Fig. 4
and Table 1), suggesting that the defect in BMP signaling
blocked normal response of bone cells to mechanical
stimulation.
Osteoblasts cultured from an independent bone-muscle
interaction site that does not show morphologic defects in
Bmp5clv mice responded normally to mechanical strain in
vitro (femur trochanter osteoblasts; Fig. 4). The anatomic
site-specificity of osteoblast response to mechanical stim-
uli in Bmp5clv mice is consistent with the specificity of the
skeletal defects seen at the tissue level of these mutants.
Furthermore, muscle fibroblasts isolated from the deltoid
of both wild-type and Bmp5clv mice showed normal
changes in morphology and orientation after mechanical
stimulation in vitro (Fig. 4 and Table 1), suggesting that
Table 1: Response of primary osteoblasts and muscle fibroblasts to cyclic mechanical strain. 
Cell type [noggin](µg/mL) Degree angle from strain axis P value
wt DT Os - 82.3 ± 7.0 (91) -
Bmp5clv DT Os - 52.2 ± 24.5 (80) <0.001
wt FT Os - 80.9 ± 8.5 (95) -
Bmp5clv FT Os - 82.5 ± 6.5 (93) NS
wt DM Fib - 85.7 ± 3.8 (106) -
Bmp5clvDM Fib - 84.6 ± 4.7 (101) NS
wt DT Os 0 83.5 ± 5.7 (123) -
0.1 80.2 ± 8.7 (148) <0.01
1 71.1 ± 16.7 (111) <0.001
10 62.3 ± 21.5 (107) <0.001
Cell type Time strained (min) % Nuclear SMAD P value (wt vs. Bmp5clv)
wt DT Os 0 7.1 ± 3.6 (94) -
10 15.4 ± 6.4 (99) -
20 34.2 ± 3.6 (139) -
30 35.8 ± 8.5 (131) -
60 32.4 ± 8.2 (124) -
24 h 8.6 ± 3.1 (146) -
Bmp5clv DT Os 0 9.1 ± 4.6 (86) NS
10 13.7 ± 5.2 (94) NS
20 14.9 ± 5.5 (101) <0.01
30 18.4 ± 4.3 (100) <0.05
60 14.7 ± 1.6 (107) <0.05
24 h 7.5 ± 4.5 (90) NS
wt FT Os 0 7.9 ± 6.3 (101) -
10 15.8 ± 8.6 (124) -
20 31.2 ± 3.3 (123) -
30 37.6 ± 1.3 (133) -
60 30.0 ± 7.3 (149) -
24 h 7.8 ± 4.3 (121) -
Bmp5clv FT Os 0 8.4 ± 2.7 (101) NS
10 12.7 ± 7.9 (126) NS
20 34.5 ± 6.1 (134) NS
30 32.4 ± 5.0 (106) NS
60 26.4 ± 9.6 (111) NS
24 h 8.2 ± 3.0 (105) NS
Values displayed are means ± SD of independent measurements from individual cells (cell # in parentheses) pooled from 3 experiments. p values 
between wild type and mutant data from the same cell type and time point are shown. wt = wild type, DT = deltoid tuberosity, FT = femur 
trochanter, DM = deltoid muscle, Os = osteoblast, Fib = fibroblast, NS = not significant.Page 6 of 13
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cells at these sites.
To further characterize the relationship between mechan-
ical stimulation and BMP signaling, we studied the effect
of mechanical strain on cellular translocation of SMAD
proteins, key transcription factors that translocate from
the cytoplasm to the nucleus upon activation of BMP
receptors [52]. Non-strained wild-type deltoid tuberosity
osteoblasts exhibited SMAD1/5 immunoreactivity pre-
dominantly in the cytoplasm (Fig. 5 and Table 1). Within
30 minutes of applying cyclic strain to these cells, we
detected a significant increase in nuclear localization of
SMAD1/5 (Fig. 5 and Table 1). Peak nuclear localization
occurred 1 hour after mechanical stimulation, SMAD1/5
was then predominantly cytoplasmic again by 24 hours
(Fig. 5 and Table 1), at which point cells also had reori-
ented perpendicularly to the strain axis. In contrast,
SMAD1/5 in Bmp5clv deltoid tuberosity cells remained
mostly cytoplasmic before and after cyclic stretch (Fig. 5
and Table 1), demonstrating that perturbation of BMP sig-
naling by the Bmp5clv mutation disrupts bone cells' rapid
response to mechanical stretch.
While mutant osteoblasts from deltoid crest displayed
altered response to mechanical stimuli, it was unclear
whether this was due to an ongoing requirement for BMP-
mediated signaling or abnormal cell development at the
deltoid crest of Bmp5clv mice. To distinguish between these
possibilities, we tested the effect of transiently inhibiting
BMP signaling in wild-type osteoblasts cultured with
increasing concentrations of noggin, a secreted protein
that binds BMP and inhibits its activity [53]. Incubation of
adult wild-type osteoblasts with noggin produced dose-
dependent decreases in their reorientation response to
mechanical stimulation (Table 1), confirming that BMP
signaling is important in maintaining the normal
mechanical responses of osteoblasts at postnatal stages.
Altered response to mechanical stimulation in deltoid tuberosity osteoblast cells of Bmp5clv/Bmp5clv mutantsFigure 4
Altered response to mechanical stimulation in deltoid tuberosity osteoblast cells of Bmp5clv/Bmp5clv mutants. 
Cultured cells from the indicated sites were subjected to 0- or 24-h cyclic mechanical strain and visualized afterwards by indi-
rect immunofluorescence using antibodies against collagen 1 (osteoblast) or vimentin (fibroblast). After subjection to 24-h 
strain, most osteoblasts from the deltoid tuberosity of wild-type (wt) mice become spindle-shaped and reorient perpendicular 
to the strain axis (arrow). In contrast, Bmp5clv deltoid tuberosity osteoblasts display a random orientation after mechanical 
strain. Femur trochanter osteoblasts from wild-type or Bmp5clv mice both realign after mechanical strain. Deltoid muscle 
fibroblasts from wild-type or Bmp5clv mice also respond appropriately to mechanical strain.Page 7 of 13
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Although the role of BMPs in the formation of cartilage,
bone, and other tissues during embryonic development is
well-established, studies of their functions during postna-
tal development are complicated by both the requirement
of BMP signaling for many developmental events (pleiot-
ropy) and the overlapping expression and roles of multi-
ple BMPs at particular sites (partial functional
redundancy). The spontaneous Bmp5clvallele is a missense
mutation at a site that encodes the consensus cleavage
sequence of BMP5 and blocks the post-translational
processing of the BMP5 protein. Interestingly, this allele
mimics a form of dominant-negative mutation that
researchers have artificially induced in other TGF-β mem-
bers and injected into frog or fish embryos [46,48] or
expressed in transgenic animals [45,47] in attempts to
inhibit endogenous activity. The processing-defective
Bmp5clv allele identified here may be able to inactivate
multiple BMPs but only at sites of endogenous Bmp5 gene
expression, providing a unique tool to uncover new func-
tions of Bmp genes during embryonic and postnatal devel-
opment.
Skeletal analyses show that the Bmp5clv allele has a domi-
nant negative effect. Bmp5clv heterozygote animals show
skeletal defects not seen in Bmp5null heterozygotes, and
Bmp5clv homozygote animals have a worse phenotype
compared to that of Bmp5null mutants. Interestingly, stud-
ies on others TGF-β members have also described a dom-
inant negative phenomenon displayed by similar cleavage
SMAD1/5 nuclear relocalization after mechanical stimulation in deltoid tuberosity cellsFigure 
SMAD1/5 nuclear relocalization after mechanical stimulation in deltoid tuberosity cells. Resting wild-type (wt) del-
toid tuberosity osteoblasts display SMAD1/5 immunoreactivity in the cytoplasm; however, with increased duration of mechan-
ical strain SMAD immunoreactivity becomes more nuclear. At 24 hours, most of the reoriented cells again display cytoplasmic 
localization of SMAD 1/5. In contrast, cyclic strain failed to elicit any significant nuclear translocation of SMAD1/5 immunoreac-
tivity in Bmp5clv deltoid tuberosity osteoblasts during the time period tested. Nuclei were counterstained with propidium 
iodide (P.I.).Page 8 of 13
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mutant proteins exert their effect on coexpressed wild type
proteins by sequestering them into inactive complexes
[45-48]. It remains to be shown whether BMP5clv het-
erodimerizes with BMP2 or BMP6, which are co-expressed
at the deltoid crest. Inactivation of BMP2 and BMP6 by
the mutant BMP5 protein may explain why the deltoid
crest is only mildly reduced in Bmp5null mice but severely
reduced in Bmp5clv mice.
While the skeletal analysis was performed in adult Bmp5clv
mutants, given the expression of Bmp5 seen at the early
embryonic stages of humeral development in our expres-
sion studies, it is possible that BMPs exert their effect on
this structure at an early developmental stage. It will be
interesting to perform histological analysis at various
development time points to better characterize the pheno-
type of this mutation at different stages of development.
The skeletal defects we observed in the Bmp5clv mutants
are localized to specific structures. Interestingly, previous
studies show that the expression of Bmp5 is controlled by
an array of cis-acting regulatory sequences that drive Bmp5
expression at highly specific anatomical locations in the
skeleton [54,55]. Accordingly, the unique expression pat-
tern of Bmp5 may account for the specificity of skeletal
defects seen in the Bmp5clv mutants.
The deltoid tuberosity defect in Bmp5clv mice suggests that
the formation of a prominent muscle-induced bony struc-
ture in the humerus requires BMP signaling. Our biome-
chanical studies confirm that BMP signaling is
fundamental to the early response of bone cells to
mechanical stimulation. While we have shown that oste-
oblasts respond to mechanical stimulation by increasing
the nuclear translocation of SMAD1/5, others have also
shown similar in vitro activation of BMP signaling with
mechanical stimulation. Previous studies have shown ele-
vated BMP mRNA levels in response to 6 hours of tensile
stress applied to neonatal mouse calvaria [56] or cyclic
stress applied to cultured chick chondrocytes [57]. Our
results demonstrate SMAD translocation in normal oste-
oblasts in vitro within 30 minutes of mechanical stimula-
tion and show that Bmp5clv cells fail to undergo SMAD
translocation or reorientation in response to similar
mechanical strain. The altered response to mechanical
loading in vitro and the lack of muscle-induced features in
Bmp5clv mice provide strong genetic evidence that BMP
signaling is integral to the normal response of bone cells
to mechanical strain. While our data show that this muta-
tion has an impact on osteoblasts, it remains to be deter-
mined whether perturbation of BMP signaling has any
effect on chondrocytes from the deltoid crest.
While mutant osteoblasts from deltoid crest displayed
altered response to mechanical stimuli, it was unclear
whether this was due to an ongoing requirement for BMP-
mediated signaling or abnormal cell development at the
deltoid crest of Bmp5clv mice. The altered response of
wildtype deltoid crest osteoblasts to mechanical strain
when the BMP signaling pathway was blocked with nog-
gin suggests that BMPs are important in maintaining the
ability of bone cells to respond to mechanical strain post-
natally. It will be interesting to perform further biome-
chanical studies on Bmp5clv osteoblasts in the presence of
exogenous BMP5 protein to ascertain whether the Bmp5clv
mutation also affects the proper cell development of oste-
oblasts at the deltoid crest.
Conclusion
Over the years, researchers have recognized that the
mechanical response of bone strongly influences human
health and disease. Weight-bearing exercise can increase
bone mass and density and can reduce the risk of fracture
in millions of persons with predisposing factors including
osteoporosis. Numerous studies have provided a better
understanding of the mechanical stimuli that bone cells
detect, the signaling pathways that transduce mechanical
signals to the cell, and the nature of the cellular response.
This study on Bmp5clv mice shows that BMP signaling is an
important part of this mechanotransduction system in
bone. Further studies may elucidate how the BMP path-
way interacts with other signaling pathways in this proc-
ess. Modulation of BMP signaling through recombinant
protein or gene therapy may enable clinicians to potenti-
ate the benefits of weight-bearing activity to the skeleton
or improve the treatment of bony diseases caused by pro-
longed lack of mechanical stimulation.
Methods
Mouse strains and skeletal preparation
The Bmp5clv mutation was originally designated "se-4J"
when discovered as a spontaneous mutation in a back-
cross between C57Bl/6J and B6.Cg-Otop1tlt (for further
strain details, see JAX stock number 001496). The Bmp5clv
stock was maintained in the laboratory of DMK by inter-
crossing Bmp5clv/+ heterozygotes. Mutants were identified
by the short ear phenotype, and their genotype was con-
firmed by molecular typing as described in this paper. The
classical se mutation was also maintained on the C57Bl/6J
background (Jackson Laboratory stock number 000056).
Skeletons from age- and sex-matched mice from different
genotypes were fixed in 95% ethanol, processed using a
potassium hydroxide/alizarin red (Sigma) staining proce-
dure [58], disarticulated, and analyzed.
Identification of the Bmp5clv mutation
The Bmp5 open reading frame from total lung RNA of a 1-
month-old C57Bl/6J male mouse and an age- and sex-Page 9 of 13
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Reverse transcription was carried out with Superscript RT
(Gibco) using 1.5 µg of RNA and 2.5 µL of 20-µM reverse
primer (5'-CGC GGA TCC CTA GTG GCA GCC ACA CGA-
3') in a 20-µL reaction at 37°C for 1 h. Polymerase chain
reaction (PCR) was performed with Amplitaq DNA
polymerase (Perkin-Elmer) in a 50-µL reaction containing
1 µL each of 20-µM forward (5'-CGC GGA TCC ACC ATG
CAT TGG ACT GTA TTT TTA C-3') and reverse (as above)
primers and 1 µL of the RT reaction product from above.
The PCR products were purified from a 1% regular agarose
gel with the Gene-clean kit (Bio 101), digested with
BamHI, and cloned into pBluescript II SK(+) (Stratagene).
The Bmp5 cDNA insert on both strands from multiple
clones of each genotype was sequenced with the Seque-
nase kit (United States Biochemicals) and primers that
span the Bmp5 open reading frame (primer sequences
available upon request).
The genomic region affected by the Bmp5clv mutation was
amplified with primers 1 (5'-AAA TCT GCT GGT CTT GTG
GG-3') and 2 (5'-GGG TCC TGA TGA GAG TTG GA-3') in
a 50-µL PCR reaction containing 2.5 µL each of 20-µM
primers 1 and 2 and 1.5 µL of genomic DNA. The ampli-
fied products were digested by TaqI and separated by elec-
trophoresis on a 3% low melt agarose gel.
Expression and detection of BMP5 protein
COS-7 cells were cultured in Dulbecco's modified Eagle's
medium (DMEM) supplemented with 10% fetal bovine
serum (FBS, Hyclone), 2-mM GlutaMax, 0.1-mM non-
essential amino acids, penicillin G (100 U/mL), and strep-
tomycin (100 µg/mL) at 37°C in 5% CO2/95% air and
were passaged at confluency and maintained according to
standard tissue culture practices. All tissue culture reagents
were from Gibco except as indicated otherwise.
The Bmp5 open reading frame was amplified from wild-
type or Bmp5clv homozygous mice as described above, sub-
cloned into the mammalian expression vector pCDNA3
(Invitrogen), and sequenced to ensure that no mutations
were introduced in the cloning steps. In transfection
experiments, 2 × 106 COS-7 cells were plated on a 100-
mm tissue culture dish (Corning) and transfected with 3.3
µg of DNA and 10 µL of lipofectamine (Gibco) per dish
under reduced serum condition for 7 h (as instructed by
the manufacturer). The transfected cells were allowed to
recover in full medium for 5 h, at which point the normal
medium was replaced with reduced serum medium
(growth medium with 1% FBS, 3 mL/plate). After ~60 h,
the conditioned media from 2 identically treated plates
were collected and pooled, clarified by centrifugation,
made 2% SDS by addition of a 10% SDS stock, boiled for
10 min, and aliquoted and stored at -20°C.
Recombinant protein containing murine BMP5 pro
region (amino acids 1–310) fused with thioredoxin was
expressed under the IPTG-inducible pET32 system in
BL21 E. Coli bacterial cells as instructed by the manufac-
turer (Novagen). Briefly, 8 L transformed bacterial culture
was grown to a density of OD600 ~0.5 and induced with
1-mM IPTG for 4 h at 37°C. Cells were collected by cen-
trifugation and resuspended in Buffer A (6-M Guanidine
HCl, 0.1-M NaH2PO4, 0.01-M Tris pH 8.0, 5 mL/g cell
pellet weight), and the clarified supernatant was incu-
bated with Ni-NTA nickel resin beads (Qiagen) for 1 h at
room temperature (RT). The beads were washed with 10
volumes of Buffer A, 10 volumes of Buffer B (8-M urea,
0.1-M NaH2PO4, 0.01-M Tris pH 8.0), 10 volumes of
Buffer C (8-M urea, 0.1-M NaH2PO4, 0.01-M Tris pH 6.3)
with 5-mM imidazole, 10 volumes of Super Buffer C
(Buffer C plus 250-mM NaCl, 0.5% Tween-20, 10-mM β-
mercaptoethanol, 100-mM imidazole), and 2 washes of
10 volumes of Buffer C with 20-mM imidazole. Bound
protein was eluted by boiling the beads in 2.5× Laemmli
buffer. Polyclonal antibodies against the BMP5 pro
domain (anti-PRO) were raised by immunizing rabbits
with recombinant BMP5 pro region protein at the Berke-
ley Antibody Company. Monoclonal antibodies against
the human BMP5 mature domain (anti-MAT) were pro-
vided by Genetics Institute, Inc., and were shown to cross-
recognize the highly conserved murine BMP5 mature
region.
For western blot analysis, 60 µL of the processed SDS sam-
ples were boiled for 5 min in reducing Laemmli buffer,
fractionated on a 15% SDS-polyacrylamide gel, and trans-
ferred onto nitrocellulose. The membrane was incubated
at RT for 3 h in blocking solution (5% non-fat dried milk
in 150-mM NaCl, 10-mM Tris pH 8.0, and 0.05% Tween-
20), probed at RT for 12 h with anti-BMP5 primary anti-
bodies (anti-PRO 1:667 or anti-MAT 1:172) diluted in
blocking solution, and incubated for 1 h at RT in blocking
solution containing donkey anti-rabbit-IgG coupled to
horseradish peroxidase diluted 1:5000 (anti-PRO) or
sheep anti-mouse-IgG coupled to horseradish peroxidase
diluted 1:1000 (anti-MAT). Signals on the blot were
detected by the ECL system (Amersham).
In situ hybridization
Forelimbs were dissected from E13.5 CD1 embryos, fro-
zen immediately in O.C.T. embedding medium (VWR),
and stored at -80°C. Twelve-micrometer cross sections of
the humerus at the level of the deltoid tuberosity were col-
lected with a cryostat microtome and were processed, pre-
hybridized, and hybridized with digoxygenin-labeled
cRNA probes, as described in previously published proto-
cols [40]. Bmp probes were generated by in vitro transcrip-
tion of linearized constructs containing 200- to 500-bp
DNA inserts from the pro region or untranslated region ofPage 10 of 13
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the washing conditions and the methods used to detect
the labeled signal have been published previously [40].
Isolation of primary osteoblasts and muscle fibroblasts
Primary osteoblast and muscle fibroblast isolates from
sex-matched 10-month-old C57Bl/6J and Bmp5clv mice
were established. Under microscopy, the humerus was
exposed and the surrounding musculature was dissected
off the bone. A ~3-mm segment of the humerus contain-
ing the deltoid tuberosity (wild type) or the deltoid mus-
cle attachment site (Bmp5clv) was removed. Similarly, a ~5-
mm segment of the femur shaft containing the femoral
trochanter was dissected from each mouse. The marrow
cavity of the bone segments was flushed with ice cold
phosphate-buffered saline, and the bone was rinsed in
phosphate-buffered saline containing penicillin G (200
U/mL), streptomycin (200 µg/mL), and amphotericin B
(0.5 µg/mL). The rinsed bones were minced into small
pieces with a bone cutter in 2 mL dissociation medium
(21.3-mM Tris pH 7.4, 111.2-mM NaCl, 5.4-mM KCl, 1.3-
mM MgCl2, 0.5-mM ZnCl2, and 13-mM glucose supple-
mented with type II collagenase [5 U/mL], elastase [6.25
U/mL], D-sorbitol [18.22 mg/mL], and chondroitin sul-
fate [6 mg/mL]) and digested at 37°C for up to 180 min.
At 10, 20, and 30 min and every 30 min thereafter, the dis-
sociated cells were removed with the medium and added
to 1 volume of FBS (Invitrogen), and a fresh 2 mL of dis-
sociation medium was added to the bone fragments. Cells
from the 10–20 min, 30–90 min, and 120–180 min time
points were pooled and recovered by centrifugation,
resuspended in osteoblast growth medium (αMEM with
10% FBS, 10% horse serum [Invitrogen], 2-mM
GlutaMax, and 0.1-mM nonessential amino acids) sup-
plemented with penicillin G (100 U/mL), streptomycin
(100 µg/mL), and amphotericin B (0.25 µg/mL), and
plated in a 175-cm2 tissue culture flask. The plated cells
were allowed to attach for 72 h at 37°C in 5% CO2/95%
air, and non-adherent cells were rinsed off. Fresh growth
medium with antibiotics and antimycotics was replaced
every 4 days until the osteoblasts reached confluency (typ-
ically ~14 days after initial plating), when they were pas-
saged and maintained similarly afterwards. An aliquot of
cells from each flask was plated separately at first passage
and assayed for alkaline phosphatase activity, an indicator
of osteogenic differentiation, using the AP assay kit
(Sigma). Cultures containing fewer than 50% alkaline
phosphatase-positive cells were discarded. Antibiotics and
antimycotics were omitted from the growth medium after
the second passage. Experiments were typically performed
on cells from the second and third passages.
A previously described fibroblast isolation protocol [60]
was used to harvest primary fibroblasts from the distal
third of the deltoid muscle by enzymatic dissociation. The
fibroblasts were maintained in DMEM with 15% FBS, 2-
mM GlutaMax, and 0.1-mM non-essential amino acids
supplemented with penicillin G (100 U/mL), streptomy-
cin (100 µg/mL), and amphotericin B (0.25 µg/mL).
Mechanical stimulation and indirect immunofluorescence
A total of 5 × 104 osteoblasts or 1 × 104 muscle fibroblasts
per well were plated on BioFlex 6-well plates with collagen
1-coated flexible membrane bottoms (Flexcell) and
allowed to attach overnight. For noggin treatment, fresh
medium containing no (control) or recombinant mouse
noggin protein (R&D, 0.1–10 µg/mL) was replaced 3 h
before mechanical strain. The plates were mounted onto
the base plate of a Flexercell FX-4000T system (Flexcell)
and left undisturbed for 1 h before initiation of mechani-
cal stimulation to minimize the extraneous strain and
fluid stress secondary to handling of the plates.
Cyclic uniform radial strain was applied with -70 kPa neg-
ative pressure to produce a 15% maximum elongation of
the membranes in square wave cycles of 10 sec strain and
10 sec relaxation at a frequency of 0.05 Hz or 3 cycles per
minute.
We visualized the cells using a previously described indi-
rect immunofluorescence protocol [60] with the follow-
ing modifications. The cells were fixed in ice-cold 50%
methanol/50% acetone at -20°C for 20 min; blocked in
10% serum with 0.5% Triton-X (Biorad); and probed with
primary antibodies against type I collagen (Chemicon),
vimentin (Sigma), or SMAD1/5 (Chemicon) and second-
ary antibodies coupled to FITC or Cy3 (Sigma). Nuclei
were counterstained with propidium iodide (Molecular
Probes). The round flexible membrane was cut into equal
quadrants and each quadrant was mounted onto a slide.
This allowed the angles between the cell axis and the
strain field to be measured accurately. Angles were meas-
ured from 80–150 cells per condition over 3 independent
experiments, and SMAD subcellular localization was
determined from 80–150 cells per condition over 3 inde-
pendent experiments. Images were captured with a Retiga
1300 digital camera (QImaging) attached to a Leica DM
IRB microscope and were processed with Northern Eclipse
6.0 software (MVIA). P values and statistical significance
between the means of each group were determined by the
modified Bonferroni's t test.
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